Cambridge, UK - Last week, Governor Chris Christie and several New Jersey representatives from the life science community attended a roundtable at One Nuclues Research Facility during their visit to the United Kingdom. The delegation toured the facility and discussed how they could improve international relations in the biological sciences and healthcare industry.
"The goal for me and the delegation is to strengthen the business, cultural and diplomatic ties between our state and the United Kingdom," Christie said in a conference call with reporters before arriving in London Sunday, noting that 180 New Jersey-based companies do business with England. "We have a durable relationship with Great Britain. Our goal is just to make it stronger," he said.
The delegation consisted of the Governor's policy adviser Amy Cradic; Rutgers University President Robert Barchi and Rutgers Senior Vice President Chris Molloy; Port Authority board member and Senior Vice President of Celgene Rich Bagger and Choose New Jersey President Michele Brown.
The trip was primarly funded and planned by Choose New Jersey, the state's nonprofit established by Governor Christie to foster investment in the state.
According to Choose NJ, "New Jersey’s concentration of hospitals, medical schools and universities, combined with the state’s population density and outstanding transportation infrastructure, makes the state a prime location for clinical trials. In fact, there are currently 2,200 open and active trials underway right now in the state. In the growing field of translational research, programs are already underway in facilities such as the Cancer institute of New Jersey, the Robert Wood Johnson Medical School, and the Pediatric Clinical Research Center."
For photos from the event: http://www.state.nj.us/governor/media/photos/2015/20150202a.shtml
The delegation consisted of the Governor's policy adviser Amy Cradic; Rutgers University President Robert Barchi and Rutgers Senior Vice President Chris Molloy; Port Authority board member and Senior Vice President of Celgene Rich Bagger and Choose New Jersey President Michele Brown.
The trip was primarly funded and planned by Choose New Jersey, the state's nonprofit established by Governor Christie to foster investment in the state.
According to Choose NJ, "New Jersey’s concentration of hospitals, medical schools and universities, combined with the state’s population density and outstanding transportation infrastructure, makes the state a prime location for clinical trials. In fact, there are currently 2,200 open and active trials underway right now in the state. In the growing field of translational research, programs are already underway in facilities such as the Cancer institute of New Jersey, the Robert Wood Johnson Medical School, and the Pediatric Clinical Research Center."
For photos from the event: http://www.state.nj.us/governor/media/photos/2015/20150202a.shtml
